In the pivotal SURMOUNT-1 clinical trial, participants taking the highest dose of tirzepatide achieved an average body weight reduction of up to 22.5% over 72 weeks
Diabetes Care 37 , 20242027 (2014)
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
Effects of glucagon-like peptide-1 receptor agonists on histopathological and secondary biomarkers of non-alcoholic steatohepatitis: A systematic review and meta-analysis
ACE inhibitors, another common blood pressure medication class, can cause a persistent dry cough that worsens the subjective sensation of oral dryness
Prescribers who have expertise in obesity medicine While any licensed physician can prescribe GLP-1s, the nuances of safe and effective treatment are best handled by specialists in obesity medicine, primary care, endocrinology, or related fields